Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 6 relevant journals, 14 Conferences, 177 National Symposiums are presently dedicated exclusively to Phaeochromocytoma and about 164 articles are being published on Phaeochromocytoma.
A pheochromocytoma is a neuroendocrine tumor of the medulla of the adrenal glands. Up to 25% of pheochromocytomas may be familial. Pheochromocytoma is a tumor of the multiple endocrine neoplasia syndrome, type IIA and type IIB (also known as MEN IIA and MEN IIB, respectively). The other component neoplasms of that syndrome include parathyroid adenomas, and medullary thyroid cancer.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Mutations in the autosomal RET proto-oncogene drives these malignancies. Common mutations in the RET oncogene may also account for medullary sponge kidney as well. The diagnosis can be established by measuring catecholamines and metanephrines in plasma (blood) or through a 24-hour urine collection. Surgical resection of the tumor is the treatment of first choice, either by open pheochromocytoma or else laparoscopy.
Chromaffin cells (CC) produce catecholamines; oxidation of fresh tissue samples gives them their characteristic grey-brown stain. Although CC are mainly located in the adrenal medulla, accessory adrenal tissue comprising both cortical and medullary elements has been reported to be localized in the celiac plexus area in 16% of autopsies. Extra-adrenal chromaffin cells give rise to paragangliomas (PGLs; tumors situated along the paravertebral and paraaortic axes). Paragangliomas that are localized in the adrenal medulla are called pheochromocytomas (PHEOs; or more uncommonly termed adrenal medullary PGLs). In the absence of universally established criteria for defining malignancy, a PHEO is considered to be malignant in the presence of metastases.
Market Analysis:
According to statistics of International Diabetes Foundation (IDF), in 2014, the global population diagnosed with diabetes was around 375 million, and is anticipated to grow to reach 592 million by the end of 2035. The global market value for diabetes was $38 billion in 2010 and is is expected to increase to $51.2 billion in 2015.
GBI Research's analysis shows that the overall global endocrinology market for the four indications was valued at $6.0 billion in 2010. It grew from $4.0 billion in 2004 at a CAGR of 6.9%. The market is expected to witness comparatively moderate growth with a CAGR of 8.0% between 2010 and 2018, and is estimated to reach $11.2 billion in 2018. NIH funding on Endocrinology is $851,814 from 2010-Present.
According to statistics of International Diabetes Foundation (IDF), in 2013, the global population diagnosed with diabetes was around 355 million, and is anticipated to grow to reach 592 million by the end of 2035.
As of 2015, there are around 180 new formulations under pipeline studies to treat diabetes, out of which, around 13 are waiting for approval from regulatory bodies.
The market is expected to witness comparatively moderate growth with a CAGR of 8.0% between 2010 and 2018, and is estimated to reach $11.2 billion in 2018.
A new report by vision gain predicts the world market for diabetes medications will reach $55.3bn in 2017. The antidiabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023.
List of Best International Conferences:
1. 3rd Endocrinology Conference, November 02-04, 2015 Atlanta, Georgia, USA
2. Hormones and Steroids conference
June 23-25, 2016 in New Orleans, USA
3. 6th Endocrinology conference
December 5-7, 2016 in Baltimore, USA
4. Metabolic syndrome conference
October 20-22, 2016
5. Pancreatic Disorders conference
May 12-14, 2016, Chicago, USA
6. Clinical Endocrinology Update, September 10-12, 2015, Miami, Florida, United States
7. Endocrine Essentials Live, September 20, 2015, Atlanta, Georgia, United States
8. 15th International Thyroid Congress (ITC), October 18-23, 2015, Florida, USA
9. Endocrine Society of Sri Lanka 7th Annual Academic Sessions, October 1 - 4, 2015, Colombo , Sri Lanka
10. EndoBridge, October 15-18, 2015, Antalya, Turkey
Relevant Society and Associations
Endocrine Society
Society for Endocrinology
European Society of Endocrinology
American Association of Clinical Endocrinologists
International Society of Endocrinology
Pediatric Endocrine Society
Canadian Diabetes Association
International Diabetes Federation
Diabetes Australia
Austrian Diabetes Association
European Thyroid Association
Asian Association of Endocrine Surgeons
British Association of Endocrine & Thyroid Surgeons
Indian Thyroid Society
Thyroid Society of Canada
Thyroid Cancer Survivor’s Association
National Thyroid Cancer Institute
Australian Thyroid Association
Thyroid Association of New Zealand
Companies
Abbott Laboratories,
Novartis International
Eli Lilly and Company
Novo Nordisk,
Facet Biotech Corporation
Alacer Corporation
Sanofi and Pfizer Inc.
This page will be updated regularly.
This page was last updated on November 5, 2024
